Verrica Pharmaceuticals Inc.

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Verrica Pharmaceuticals Inc’s recently made public that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Verrica Pharmaceuticals Inc’s recently made public that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0

Stock Earnings

Verrica Pharmaceuticals Inc’s recent filing unveils that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Verrica Pharmaceuticals Inc’s recently made public that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0

Stock Earnings

Verrica Pharmaceuticals Inc’s recent filing unveils that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0

Insiders Updates

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Verrica Pharmaceuticals

Insiders Updates

Verrica Pharmaceuticals Inc’s filing revealed that its CHIEF LEGAL OFFICER Hayes Christopher G. unloaded Company’s shares for reported $69647.0 on

Tag: Verrica Pharmaceuticals Inc.